Oarsman Capital’s Novanta NOVT Stock Holding History

Oarsman Capital’s Portfolio NOVT Stock Details NOVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-106	Closed	-$16.2K	–	630
2024 Q4	$16.2K	Buy	106 +6	+6%	+$1.02K	﹤0.01%	631
2024 Q3	$17.9K	Buy	+100	New	+$17.4K	﹤0.01%	614

Other funds holding NOVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oarsman Capital's NOVT Position: Q1 2025 in Review

Oarsman Capital sold out of Novanta (NOVT) in Q1 2025, closing a stake of 106 shares — an estimated $16.2K sold.

Oarsman Capital first reported a position in NOVT in Q3 2024 and held it in 2 quarters. The position peaked at $17.9K in Q3 2024. 324 funds tracked by Wall St. Rank hold NOVT as of Q1 2025.

Oarsman Capital reported no remaining Novanta position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 106 Novanta shares in Q1 2025, an estimated $16.2K.
Oarsman Capital first reported a position in Novanta in Q3 2024 and held it in 2 quarters.
Oarsman Capital's Novanta position peaked at $17.9K in Q3 2024.
324 funds tracked by Wall St. Rank held Novanta as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.